Clinical presentation with consequences and laboratory diagnosis of multi and extensive drug resistance in typhoid cases
DOI:
https://doi.org/10.59736/IJP.22.02.894Keywords:
Antibiotic Resistance, Drug Resistance, Health Care, Typhoid FeverAbstract
Background: Enteric fever is among the major problem in the health care settings of developing countries like Pakistan. Unjudicial use and over the counter availability of antibiotics lead to the emergence of multi drug resistant and extensive drug-resistant strains of salmonella outbreak which demonstrate severity of disease of the disease. Our objective is to determine the clinical presentation, consequences and antibiotic susceptibility patterns of Multi Drug Resistant (MDR) typhoid and Extensive drug resistance (XDR) typhoid cases.
Methods: The study was conducted in the department of Microbiology, Dow Diagnostic Reference and Research Laboratory, Dow University of Health Sciences. All laboratory proven Salmonella positive cultures samples were selected from laboratory that were either fully or partially treated, or were taking anti-Salmonella. Clinical trends along with clinical outcomes were assessed from clinical presentation. Furthermore, Demographic details were noted. Detailed history about the presenting illness with examination findings and medications were recorded.
Results: A total of 333 patients had positive blood culture for enteric fever, in which maximum number of XDR cases 84% (n=281) were observed in blood cultures followed by MDR salmonella in 16 % (n=52). Meropenem and azithromycin didn’t show any resistance in our study.
Conclusion: Our study has demonstrated that pediatric population is more vulnerable for developing salmonella infection. Carbapenems and azithromycin are among the last choices for the treatment of XDR cases. Analysis of our results imply stress on the implementation of preventive measures for spread of enteric fever including proper diagnosis, vaccination and good sanitation system
References
Srinivasan M, Sindhu KN, Giri S, Kumar N, Mohan VR, Grassly NC, et al. Salmonella Typhi Shedding and Household Transmission by Children With Blood Culture-Confirmed Typhoid Fever in Vellore, South India. J Infect Dis. 2021;224(Supple 5):S593-S600.
Qamar FN, Hussain W, Qureshi S. Salmonellosis Including Enteric Fever. Pediatr Clin North Am. 2022;69(1):65-77.
Gibani MM, Britto C, Pollard AJ. Typhoid and paratyphoid fever: a call to action. Curr Opin Infect Dis. 2018;31(5):440-8.
Typhoid and Paratyphoid Fever - A Call to Action: Erratum. Curr Opin Infect Dis. 2019; 32(3):293.
Radhakrishnan A, Als D, Mintz ED, Crump JA, Stanaway J, Breiman RF, et al. Introductory Article on Global Burden and Epidemiology of Typhoid Fever. Am J Trop Med Hyg. 2018; 99(3_Suppl):4-9.
Shahid S, Mahesar M, Ghouri N, Noreen S.Areviewof clinical profile, complications and antibiotic susceptibility pattern of extensively drug-resistant (XDR) Salmonella Typhi isolates in children in Karachi. BMC Infect Dis. 2021;21(1):900.
Michael Hughes GA, Louise Francois Watkins. CDC Yellow Book 2024 USA2024
Akram J, Khan AS, Khan HA, Gilani SA, Akram SJ, Ahmad FJ, et al. Extensively Drug-Resistant (XDR) Typhoid: Evolution, Prevention, and Its Management. Biomed Res Int. 2020; 2020:6432580.
Pustake M, Giri P, Tambolkar S, Nayak S. Extensively Drug-Resistant Typhoid Fever: A Call to Action. Indian J Community Med. 2022; 47(1):153-4.
Haqqi A, Khurram M, Din MSU, Aftab MN, Ali M, Ahmed H, et al. COVID-19 and Salmonella Typhi co-epidemics in Pakistan: A real problem. J Med Virol. 2021;93(1):184-6.
Institute CaLS. CLSI. Performance Standards for Antimicrobial Susceptibility Testing. 33 edition. CLSI supplement M100. 2023.
Fida S, Mansoor H, Saif S, Iqbal J, Khan AQ. Clinical Perspectives of Multiple and Extensively Drug-Resistant Typhoid; result from a tertiary care hospital from Pakistan. J Infect Dev Ctries. 2021;15(4):530-7.
Amir A, Ikram A, Salman M. Emergence of Novel Mutations in Extensively Drug-Resistant Salmonella enterica Serovar Typhi from Pakistan. Antimicrob Agents Chemother. 2020; 64(8).
Ahmad M, Shah N, Siddiqui MA. Frequency and Antibiotics Sensitivity Pattern of Culture-Positive Salmonella Typhi in Children. J Coll Physicians Surg Pak. 2023; 33(3):303-7.
Ashraf Hussain M, Ahmed I, Akram S, Khan MA, Ali S, Amir M. Extensively Drug-Resistant Typhoidal Salmonellae: Are These Bugs Swarming Into Suburban and Rural Areas of Pakistan? Cureus. 2022; 14(6):e26189.
Ajibola O, Mshelia MB, Gulumbe BH, Eze AA. Typhoid Fever Diagnosis in Endemic Countries: A Clog in the Wheel of Progress? Medicina (Kaunas). 2018; 54(2).
Saeed N, Usman M, Khan EA. An Overview of Extensively Drug-resistant Salmonella Typhi from a Tertiary Care Hospital in Pakistan. Cureus. 2019;11(9):e5663.
Zakir M, Khan M, Umar MI, Murtaza G, Ashraf M, Shamim S. Emerging Trends of Multidrug-Resistant (MDR) and Extensively Drug-Resistant (XDR) Salmonella Typhi in a Tertiary Care Hospital of Lahore, Pakistan. Microorganisms. 2021;9(12).
Saha MR, Dutta P, Palit A, Dutta D, Bhattacharya MK, Mitra U, et al. A note on incidence of typhoid fever in diverse age groups in Kolkata, India. Jpn J Infect Dis. 2003;56(3):121-2.
Ali A, Ali HA, Shah FH, Zahid A, Aslam H, Javed B. Pattern of antimicrobial drug resistance of Salmonella Typhi and Paratyphi A in a Teaching Hospital in Islamabad. J Pak Med Assoc. 2017; 67(3):375-9.
Ashley T Longley CH, Kashmira Date, Stephen P Luby, Jason R Andrews, Samir K Saha, Isaac I Bogoch, Mohammad T Yousafzai, Denise O Garrett, Farah N Qamar. Illness severity and outcomes among enteric fever cases from Bangladesh, Nepal, and Pakistan: data from the surveillance for enteric fever in Asia project, 2016–2019. Clinical Infectious Disease. November, 2020; 71(_3): S222–S31.
Khan M, Khattak MT, Gul A, Riaz M, Zahra FT. A comparable risk of extensively drug-resistant typhoid fever in the pediatric cohort during the COVID-19 pandemic. Int J Health Sci (Qassim). 2024; 18(1):24-8.
Bhan MK, Bahl R, Bhatnagar S. Typhoid and paratyphoid fever. Lancet. 2005; 366(9487):749-62.
Herekar F, Sarfaraz S, Imran M, Ghouri N, Shahid S, Mahesar M. Clinical spectrum and outcomes of patients with different resistance patterns of Salmonella enterica. Pak J Med Sci. 2022;38(2):356-61.
Anabire NG, Aryee PA, Helegbe GK. Hematological abnormalities in patients with malaria and typhoid in Tamale Metropolis of Ghana. BMC Res Notes. 2018; 11(1):353.
Mazkour S, Shekarforoush SS, Basiri S, Nazifi S, Yektaseresht A, Honarmand M. Effects of two probiotic spores of Bacillus species on hematological, biochemical, and inflammatory parameters in Salmonella Typhimurium infected rats. Sci Rep. 2020; 10(1):8035.
Rana BSJBP, S. K. Hematological parameters of Salmonella typhi and paratyphi culture positive patients from Kathmandu Valley, Nepal. Journal of Institute of Medicine Nepal (JIOMN). 2015; 37(3):40.
Song W, Shan Q, Qiu Y, Lin X, Zhu C, Zhuo Z, et al. Clinical profiles and antimicrobial resistance patterns of invasive Salmonella infections in children in China. Eur J Clin Microbiol Infect Dis. 2022;41(10):1215-25.
Alwan A. Highlights of WHO's work in the Eastern Mediterranean Region (Editorial). East Mediterr Health J. 2016; 22(6):363-7.
Qamar FN AA, Kazi AM, Khan E, Zaidi AKM. A three-year review of antimicrobial resistance of Salmonella entericaserovarsTyphi and Paratyphi A in Pakistan. J Infect Dev Ctries. 2014; 8:981-6.
Butaye P, Michael GB, Schwarz S, Barrett TJ, Brisabois A, White DG. The clonal spread of multidrug-resistant non-typhi Salmonella serotypes. Microbes Infect. 2006; 8(7):1891-7.
Anwar T RH, Jamil MF, Safdar S, Amir MR, Altaf A, et al. Extended drug resistance in children with typhoid fever. Prof Med J. 2020; 27(3):581-7.
Qureshi S, Naveed AB, Yousafzai MT, Ahmad K, Ansari S, Lohana H, et al. Response of extensively drug resistant Salmonella Typhi to treatment with meropenem and azithromycin, in Pakistan. PLoS Negl Trop Dis. 2020; 14(10):e0008682
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Mehwish sajjad Mehmood, Ambreen Fatima, Iftekhar Ahmed, Fouzia Zeeshan Khan, Hareem Gohar, Salma Salman
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Readers may “Share-copy and redistribute the material in any medium or format” and “Adapt-remix, transform, and build upon the material”. The readers must give appropriate credit to the source of the material and indicate if changes were made to the material. Readers may not use the material for commercial purpose. The readers may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
